Many organizations collect and make available perinatal data for research and quality improvement initiatives. Analysis of existing data and use of retrospective study design has many advantages for perinatal researchers. These advantages include large samples, inclusion of women from diverse groups, data reflective of actual clinical processes and outcomes, and decreased risk of direct maternal and fetal harm. We review 11 publicly available datasets relevant to perinatal research and quality improvement, detail the availability of interactive websites, and discuss strategies to locate additional datasets. While analysis of existing data has limitations, it may provide statistical power to study rare perinatal outcomes, support research applicable to diverse populations, and facilitate timely and ethical well-woman research immediately relevant to clinical care.
INTRODUCTION
Conduct of research and quality improvement is increasingly a professional expectation for midwives and other perinatal care providers. More than 7% of full-time midwives in the United States conduct research, 1 and many more conduct quality improvement and benchmarking. The Core Competencies for Basic Midwifery Practice specify that research and quality improvement skills are entry-level professional expectations. 2(p2) Additionally, many certified nursemidwives (CNMs), certified midwives (CMs), and advanced practice nurses pursue doctoral training to facilitate data use for assessment and/or outcomes improvement. Though only 4.1% of CNMs/CMs had a doctoral degree in 2001, 11.6% of CNMs/CMs were doctorally prepared in 2012, and numbers continue to increase. 1, 3, 4 There is clear need for more and increasingly rigorous science to guide improvements in perinatal care. Neonatal outcomes in the United States have shown only modest improvements in the past 5 years 5, 6 and are worse than those in resource-comparable nations. 7 Importantly, US maternal morbidity and mortality is increasing. 8 These factors and striking health disparities in maternity outcomes between racial and ethnic groups signal a need for stronger perinatal research and effective quality improvement. 9, 10 National organizations such as the American College of Nurse-Midwives (ACNM), the American College of Obstetricians and Gynecologists (ACOG), and the Agency for Healthcare Research and Quality (AHRQ) have called for improvement in the provision of high-quality, evidence-based perinatal care. [11] [12] [13] High-quality perinatal data are essential to reaching this goal. Though experimental trials have many strengths for use in quality improvement and research, and remain the scientific gold standard, they frequently are limited by small samples lacking statistical power to detect changes [Correction added after publication August 22, 2017 : "in the School of Nursing at Oregon Health and Science University" was added.] in important maternal, fetal, or neonatal outcomes. In addition, it is sometimes not feasible to incorporate randomization or blinding in research involving pregnant women. These limitations may be especially problematic in the conduct of well-women perinatal research because this population may be disinclined to participate and severe outcomes are rare.
Strengths of Dataset Analysis for Perinatal Research
Large existing datasets offer a wealth of information about the effects of health care services and treatments on maternalchild health outcomes. Arguably, the most important strength of utilizing large datasets for well-woman perinatal research is that these datasets allow for study of rare outcomes (eg, cord prolapse) infrequently encountered in a single location or trial. Since this research does not change care routinely provided to pregnant women, fewer ethical considerations may emerge, potentially facilitating expedited institutional review board (IRB) approval and shortening time between identifying a scientific gap and disseminating research findings. Further, datasets enable the aggregation of information from diverse women in various settings, ideally using clearly defined operational definitions for each measure. 8 In experimental studies, the intervention is often tightly controlled and provided to a homogenous sample in order to ensure treatment fidelity and boost internal validity; however, strict protocols limit external validity and generalizability.
14 In addition, large databases may include greater variations in treatment, practice patterns, and care settings, which more accurately capture the variability of pregnancy, labor, and birth processes and outcomes as well as women's choices. This may enable broader and more accurate insight into the effects of maternity care systems and interventions in existing clinical settings. 15 Analysis of such large existing datasets frequently provides sample sizes with the statistical power to assess care using fewer resources than randomized controlled trials (RCTs). Existing data have such value that the National Institutes of Health (NIH) requires researchers receiving more than $500,000 in federal funding to make their data available for secondary analysis.
✦ Existing datasets enable analyses regarding health care service system outcomes, treatment effects, and rare outcomes.
✦ Datasets aggregate information from prior research or routine medical care and administrative processes. These large datasets are available from local, state, and federal agencies and professional organizations, as well as medical institutions.
✦ There are a variety of existing datasets for perinatal research; each has unique data and limitations. Researchers should become familiar with a dataset's provenance, contents, validity, and completeness of data elements prior to use.
✦ Research using such datasets could accelerate well-woman perinatal outcomes investigation due, in part, to large sample sizes and inclusion of diverse participants.
Limitations of Dataset Analysis for Perinatal Research
Analysis of large, existing maternal-child health datasets also has several limitations. While data analysis may produce information that accurately reflects maternity care processes and outcomes, data are often affected by confounding bias (participants and/or providers select treatment or nontreatment in nonrandom ways), introducing differences into treatment groups and bias into effect estimation. Also important, large existing datasets constrain research questions. For example, a researcher may wish to study the pregnancy outcomes of nulliparous women carrying a term, single, vertexpresenting fetus (NTSV), but a dataset captures only whether women are nulliparous, term, and with a singleton pregnancy and does not include fetal presentation. The researchers must then choose to study nulliparous, term, singleton pregnancies or to pursue the question with a different dataset. The conduct of secondary data research is characterized by many similar branching decision points. For this reason, researchers must become thoroughly familiar with a dataset: its provenance, contents, validity, and completeness of all relevant data elements. The investigators should use this knowledge to frame research questions. In our experience, this process is an iterative and, ideally, team-based endeavor. Although this process is recursive and defines the questions that can be answered with a data resource, it does not supplant the scientific method (eg, observation, hypothesis formulation, and testing) central to any science. Collection and entry errors are a universal feature of datasets. Primary investigators may have access to the personnel, equipment, or original data (eg, an electronic health record) involved in the error, enabling correction of errors. In contrast, with secondary analysis or retrospective research, it may be impossible to obtain further information, including how errors arose. These limitations must be thoughtfully considered and weighed against the strengths of secondary analysis.
The purpose of this article is to review publicly available datasets for study of perinatal care in the United States. We will describe current databases with perinatal-health content, detailing the benefits and limitations of using these data for quality improvement and research. In addition, we will highlight new analytic approaches that increase the validity of dataset analysis. Additional datasets and analytic techniques are available; we highlight those most relevant to perinatal sciences.
APPROACH
We identified potentially relevant perinatal databases for review and invited input from maternity care clinical scientists and epidemiologists across the country. Informed by this comprehensive list, we discussed the merits of inclusion of each dataset as a group; through this iterative process, we refined the selection of databases. The entire author team determined which databases were most pertinent for perinatal and health services research, quality, and benchmarking. Each dataset was assigned to an initial author, who conducted the preliminary research, obtaining the information for each database, including content, value, time frame of data available, steps for access, contact information, and published examples of dataset use. A second author then confirmed information for accuracy. Differences were reconciled through author discussion and additional research. Data were sent directly between authors until aggregated by the primary author. Seeking to maximize utility and efficiency for the reader, databases were placed into perinatal and nonperinatal categories. The datasets most pertinent to perinatal research and quality improvement are organized alphabetically in the next section.
Terms used to describe analysis of existing data are defined in Table 1 . These terms differentiate research by study design and origin of the dataset. Research can be further differentiated within each of these broad terms (eg, administrative data research is a form of secondary data analysis). Though terms are not interchangeable, definitions overlap. Data analysis may use a retrospectively collected dataset (eg, a retrospective cohort study using routinely collected birth records) or use a prospectively collected dataset (eg, a study using Community Child Health Research network data).
DATABASES FOR PERINATAL RESEARCH

Agency for Healthcare Research and Quality
This agency within the US Department of Health & Human Services is focused on improving the quality, safety, effectiveness, and efficiency of health care. 19 One part of the AHRQ mission is to generate measures and data to track and improve US systems-level performance and progress. Available data from hospitals include the Healthcare Cost and Utilization Project (HCUP), the Nationwide Inpatient Sample, and State Inpatient Databases. The AHRQ database also includes Perinatal researchers might be especially interested in the HCUP data. This is one of the most comprehensive sources of US hospital data, including information on inpatient care, ambulatory care, and emergency department visits in both nationwide and state-specific databases. 20 Data capture health care delivery and patient outcomes variables over time or by region, state, or community. This information was aggregated from federal, state, and industry sources and includes patient demographics and outcomes by diagnosis and procedure codes. Among the nationwide HCUP databases, the National Inpatient Sample (abbreviated as NIS) is of particular interest for perinatal researchers as it is the largest publicly available, all-payer patient health care database in the United States. The National Inpatient Sample approximates a 20% stratified sample of all hospital discharges in US community hospitals. The stratification is to ensure that a range of geographic locations and birth locations are included. Also included in HCUP are state-specific databases; 48 states currently participate in the State Inpatient Database, and 31 states currently make this information available to the public for a reasonable fee. Detailed information is available on the AHRQ Healthcare Cost and Utilization Project website. The challenges of this dataset (eg, absence of key variables such as parity and gestational age; lack of linkage between mothers and neonates) are counterbalanced by the unique sample, which is representative of the US population and includes detailed information from many states. For this reason, HCUP data have been used to generate high-impact perinatal outcomes and care delivery systems science, such as Kozhimannil's research on variation in cesarean rates across US hospitals. 21 
American Association of Birth Centers Perinatal Data Registry
The American Association of Birth Centers (AABC) has collected data on birth outcomes since 1996. Originally known as the Uniform Data Set, it was created for birth center use. The dataset, now known as the Perinatal Data Registry, has been expanded to include variables relevant to any birth location, and information can be entered by any maternity care practice. Data from 1997 forward are available for analysis (Susan Stapleton, CNM, DNP, written communication, September 2016). Following validation, 22, 23 this dataset has been used to study birth center outcomes in the United States. 24, 25 While the focus of the dataset is on physiologic birth, 26 data are entered following the initial prenatal visit, and maternal and newborn health are followed until 6 weeks postpartum. Therefore, these data include information about the history and prenatal, intrapartum, and postpartum care of women and their children with a range of birth outcomes. 26 A list of variables is available on the website. 26 With its prospective collection, the Perinatal Data Registry contains a wealth of information about women initially planning birth center birth. However, birth center practice varies by site, especially in eligibility criteria for intrapartum admission and provider type, 25 and site-level practice information is not paired with perinatal outcomes. Another limitation is that definitions within this dataset may not match those used in other databases, and, since individual-level detail is not available, this prevents meta-analysis using data from multiple registries.
Requests for registry data are differentiated by whether only summary statistics are needed or if a dataset is required. Statistical summaries of data can be obtained through a routine data request, and IRB approval is not needed, as individuals and facilities are deidentified. If a dataset is requested, AABC requires that a formal data request and agreement be accompanied by an IRB letter verifying that the study is exempt from review. Prior to results dissemination, researchers must submit any proposed presentation, abstract, or manuscript for approval by the AABC Board of Directors and Research Committee.
Centers for Disease Control and Prevention Databases
Pregnancy Risk Assessment Monitoring System
The Pregnancy Risk Assessment Monitoring System (PRAMS) collects state-specific, population-based data on maternal attitudes and experiences before, during, and shortly after pregnancy. This US surveillance project was developed in 1987 by state-level departments of health and the Centers for Disease Control and Prevention (CDC), Division of Reproductive Health. Forty-seven states, New York City, Puerto Rico, the District of Columbia, and the Great Plains Tribal Chairmen's Health Board currently participate; 2 other states (California and Ohio) previously participated. The current jurisdictions capture 83% of US live births. To obtain data, participating states or locations use birth certificate information to sample 1300 to 3400 women who recently birthed in that locale. Most states oversample women who had low-birth-weight infants, and many states stratify by mother's race or ethnicity. State-level information is subsequently aggregated to form the full dataset.
The PRAMS questionnaire is composed of core questions asked in all states. Participants respond to a maximum of 52 questions on current PRAMS Core Questionnaire (Phase 8; released June 2016) if all topical areas are applicable to the responder. Core questions capture maternal attitudes and perceptions about the most recent pregnancy, content and source of prenatal care, maternal alcohol and tobacco consumption, physical abuse before and during pregnancy, pregnancyrelated morbidity, contraceptive use, women's knowledge of pregnancy-related issues, and infant care. States may also select from among a few hundred additional questions developed by the CDC, which reflect additional topics of interest such as mental health, injury prevention, and social support, or add their own questions. As a result, each state's questionnaire is unique, but some information is available across several or all states. The questionnaire is available in English and Spanish.
This database enables analysis of state-level or aggregate national data. Data can be used to estimate changes in population-health status, measure progress toward maternalchild health goals, and identify groups at high risk for health problems. In particular, the data contain more information on a woman's social environment, family situation, and socioeconomic position than other datasets, making it a valuable resource to study social determinants of perinatal health, especially in relationship to health behaviors. 27, 28 Although PRAMS data are self-reported, data reliability and validity are reportedly high when compared with other population-based data-collection systems, such as US birth certificates. 29 If the investigator simply wants statistics or basic analysis, the PRAMStat interactive data portal permits data queries without requiring IRB approval or dataset download. Seven different versions of the PRAMS questionnaires exist (Table 2) . Researchers may request the analytic research file by submitting an application to the CDC using the steps outlined in Table 2 . 30 
US National Vital Statistics Reports
The CDC's National Center for Health Statistics (NCHS) determines the format and content of data collected via the US Standard Certificate of Live Birth, Death, and Fetal Death. Each state is required to collect and report the data elements contained in the US Standard Certificate to the NCHS, although individual states issue their own vital record certificates and may choose to collect additional data. Datasets are divided by geographic area (United States and US territories), but the publicly available online datasets do not provide location details, such as state. These datasets are available via the CDC website without a data use agreement, IRB approval, or fee. 31 For investigators whose research questions have geographic components, access to vital statistics data with geographic information can be requested either from the National Association for Public Health Statistics and Information Systems or through the NCHS Research Data Center. Requests require a data use agreement and a processing fee and are reviewed to ensure participant confidentiality and data security measures.
A variety of datasets and years are available. Each dataset has a corresponding user's guide including definitions for terms and variables. Simpler datasets, such as birth and death data files, are available approximately 2 years after the calendar year ends. Linked datasets (eg, birth data files) joined to infant death data files enable more nuanced analysis than a lone dataset. For instance, perinatal death may be of interest only in the context of unplanned out-of-hospital births, but infant death is not on the birth certificate. In this case, a linked dataset is required, in which each record is connected between the birth dataset and the death dataset, providing the ability to analyze data from each source. Period and cohort-linked infant death data files have a longer release time, sometimes more than 5 years.
Choice of dataset and time span are important considerations as there is a trade-off between timeliness and completeness. Period-linked data are available for more recent years than cohort-linked but are cross-sectional and less preferred for detailed analytic questions. Alternately, cohort-linked data follow the group of infants born in one year for an entire year (ie, capturing death in the first year of life), optimal for detailed infant-level analyses.
While it is possible to compare outcomes across time or by region of the country, data are not uniformly collected. The most recent changes to the US Standard Certificate occurred in 2003; however, revised certificate uptake has been gradual. . 32 For analyses requiring data from the 2003 revision, the proportion of the total births using the revised certificate affects statistical power. These limitations must be weighed against the key advantage of the datasets; they contain information on every birth in the United States. Because of this advantage, NCHS data have been widely used in US population-based perinatal research and surveillance.
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Centers for Medicare & Medicaid Services
The US Centers for Medicare & Medicaid Services (CMMS) collects data on enrollment and utilization of these health care payment systems. 33 Both participant data and information on physician and professional provider characteristics, prescription drugs, and facility characteristics are available from this rich data source. Some datasets do not include identifiable information and are publicly available, while other identifiable datasets require approval. Of particular interest to perinatal researchers are the research-identifiable files, which include information on claim records for a variety of Medicaid charges, including physician services; laboratory or X-ray; and clinic services linked by diagnosis, length of stay, and payment amount. For example, a recent study using CMMS data found that approximately 20% of women of reproductive age in New York's Medicaid program received opioid prescriptions from outpatient settings from 2008 to 2013. 34 Researchers can also access personal summary data for every individual enrolled in Medicaid or Medicare during specific years and in specific states, including demographic, eligibility, and utilization information. Strengths of these datasets from the CMMS are their inclusion of rich beneficiary-level protected health information for inclusion in research analyses. Limitations of these datasets are that not all states participate in all datasets, with participation varying from year to year. The approval process to access research-identifiable information requires 3 to 4 months and can involve a fee; however, this fee is waived for student use. 35 Researchers must apply for use of identified and deidentified datasets through the Research Data Assistance Center and complete a data use agreement for access to identifiable or limited-use datasets.
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Eunice Kennedy Shriver National Institute of Child Health and Human Development Data and Specimen Hub
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has established the Data and Specimen Hub (DASH) as a mechanism for institute-funded investigators to comply with NIH datasharing policies. This repository enables other investigators to access data from the Institute's funded studies for secondary research. 16 There are 24 studies in the specimen hub that can be searched via topic (eg, high-risk pregnancy, HIV/AIDS, infant health, labor and birth), by study (eg, type, clinical research network, enrollment dates), dataset (type and format), or document type (eg, study protocol, codebook, and/or variable dictionary). 16 Researchers can create an account to request data.
Access to individual-level data requires the investigator to submit forms as outlined in Table 2 . An IRB approval may be required, but the dataset contains only deidentified data that are coded according to standards set in the Health & Human Services Regulations for the Protection of Human Subjects and the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule. The specimen hub's data access committee reviews data requests to determine whether the proposed research use is scientifically and ethically appropriate and congruent with data use limitations. Some studies receive automatic approval. Instructions are on the National Institute of Child Health and Human Development Data and Specimen Hub website. 37 
Examples of Datasets Within the Eunice Kennedy Shriver National Institute of Child Health and Human Development Data and Specimen Hub
Community Child Health Research Network
The Community Child Health Research Network was a multisite, prospective cohort study conducted from 2004 to 2009 to examine how community-, family-, and individual-level stressors influence and interact with biologic factors to affect maternal and child health. 38 The study examined how these variables are associated with disparities in pregnancy outcomes and in infant or early childhood mortality and morbidity. The research blended social, behavioral, and biomedical approaches into a community-linked study. This deidentified dataset includes 4837 people; 3079 of them postpartum women following a live birth at greater than or equal to 20 weeks' gestation and 1758 spouses. Most participants were from lower socioeconomic levels, living in African American, Latina, or white communities in 5 regions of the United States. The dataset sampled 3 urban regions, one mixed urbansuburban region, and one rural region. Examples of uses of Community Child Health Research Network data include examining racial disparities in postpartum depression, 39 testing associations between psychosocial stress and C-reactive protein in women during the first postpartum year, 40 and clarifying causal pathways between sleep and postpartum depression. 41 
Consortium on Safe Labor Dataset
The Consortium on Safe Labor (CSL) was a multisite, prospective, observational cohort study conducted between 2002 and 2008 in 12 clinical institutions (19 hospitals) located in all 9 of the ACOG districts in the United States. 42 The CSL was formed to describe contemporary labor progression, identify the most appropriate time for a cesarean birth among women with labor protraction or arrest, and explore causes of the high US cesarean birth rate. This deidentified dataset includes detailed information from electronic medical records on 228,562 births as well as additional variables regarding the woman, her labor and birth, and her neonate. 43 The CSL dataset includes information on maternal demographics, pregnancy details, labor interventions, labor outcomes, and newborn interventions and outcomes as well as information on the hospital and provider for each woman. In addition, the CSL includes repeated measures on oxytocin dosing and cervical examinations for each participant throughout labor. The CSL cohort has been analyzed in seminal studies on a variety of perinatal topics (eg, labor progression, obstetric procedure use), [44] [45] [46] [47] and is publicly available for further secondary analysis.
Maternal-Fetal Medicine Unit Network: Screening for Risk Factors for Spontaneous Preterm Delivery
This multisite, prospective, observational study was conducted from 1992 to 1995 to evaluate tests that define a group of women with at least a 2-fold increase in risk for spontaneous preterm birth. The tests evaluated included a demographic, behavioral, psychological, anthropometric, and historical profile; serum and plasma levels of various proteins such as C-reactive protein, major basic protein, and alphafetoprotein; and vaginal ultrasound evaluation of the cervix, a cervical digital examination, the presence of bacterial vaginosis and trichomonas, and both vaginal and cervical fetal fibronectin. This deidentified dataset includes 3073 women with singleton pregnancies. The primary outcome was birth at 23 to 34 weeks' gestation following spontaneous preterm labor or premature rupture of membranes.
Listening to Mothers
The Maternity Center Association's Listening to Mothers initiative aims to understand the experiences and views of US childbearing women giving birth to a single newborn in a hospital setting. Multiple variables are captured for participating women who complete online surveys about their maternal care experiences. Five national Listening to Mothers surveys have been conducted, including 3 initial pregnancy and birth surveys and 2 follow-up postpartum surveys. Results reveal gaps between women's preferences for care and the care they receive. Such detailed data on women's perinatal care experiences and perspectives are not available in other datasets and can be used by clinicians, educators, and researchers to inform maternity care practice, education, and policy. 48, 49 The datasets from these surveys are publicly available in the Odum Institute Dataverse Network Data Archive. 50 Listening to Mothers data have been used to examine the effects of the perceived support during labor and birth on women's positive and negative evaluations of their birth experiences, 51 assess racial and ethnic disparities in patient-reported communication problems and perceived discrimination in maternity care, 49 and examine the association between workplace accommodations for pregnant employees (eg, availability of paid and unpaid maternity leave) and changes in women's health insurance coverage postpartum, 48 among many other works.
Midwives Alliance of North America Statistics Project
The Midwives Alliance of North America Statistics Project (MANA Stats) datasets include data on pregnancy as well as labor and early postpartum processes and outcomes. The majority of providers contributing to this dataset are US certified professional midwives (CPMs), practicing in home or birth center settings. Approximately 30% of all US CPMs contribute to MANA Stats data-collection efforts. 52 Participation is voluntary; however, Oregon, Washington, and Vermont mandate CPM participation, and other states are considering this approach (M. Cheyney, PhD, oral communication, October 2016). A smaller proportion of data is collected by CNMs/CMs. MANA Stats comprises 3 datasets, each with different granularity for variables that predominantly capture lower-intervention care processes and outcomes of the childbearing cycle. The relatively low rate of obstetric or hospitalbased interventions within this dataset makes it particularly relevant for the study of physiologic labor and birth processes. Care outcomes are also captured for the approximately 12% of women or neonates who begin care in the out-of-hospital setting but transfer to the hospital. 53 When women initiate prenatal care with midwives who participate in MANA Stats data collection, those willing are consented for participation (Ͼ95% of eligible women consent), 52 and data about early prenatal care are entered. Additional data are entered during pregnancy, birth, and the early postpartum period. The online system alerts MANA Division of Research leadership when longitudinal data of a particular participant are missing, and processes exist to directly engage the responsible midwife to prompt completion. 52 This prospective structure and well-organized system for accountability improve data quality and validity. 52 The steps for using MANA Stats data for research are in Table 2 .
Strong Start for Mothers and Newborns Initiative Data
The Strong Start for Mothers and Newborns Initiative is a project by the US Department of Health & Human Services. Its goal is to improve maternal and infant outcomes among pregnant women with insurance coverage through Medicaid and the Children's Health Insurance Program (CHIP). 54 This 5-year initiative (2013-2018) compares women with Medicaid coverage receiving standard care versus those enrolled in one of 3 types of enhanced prenatal care: 1) maternity care homes (62.4% of sites); 2) group prenatal care (19.7% of sites); 3) and birth center care (17.8% of sites). Comparisons aim to discover if these enhanced prenatal models reduce preterm births, improve outcomes, and/or decrease cost of care during the first year of life.
The Strong Start project includes 27 awardees and 213 sites in 30 states, the District of Columbia, and Puerto Rico with an estimated sample of 80,000 women. 54 The Strong Start dataset includes participant-and program-level data collected quarterly from each site. Participant-level data include type of enhanced prenatal care model, maternal demographic characteristics, pregnancy risk characteristics, pregnancy outcomes, costs for women and infants during the first year of life, and maternal satisfaction with care. Program-level data include baseline and ongoing aggregate information on pregnancy outcomes and model descriptions. In addition, CMS is working with states to collect linked vital statistics data obtained from birth certificates, Medicaid eligibility, Medicaid claims, and encounter data on women and infants in the comparison group receiving standard care. Quality checks led by CMS are conducted annually. Initial aggregate data for project years 1 and 2 are available at the Strong Start website 54 ; the full Strong Start dataset should be completed in 2018.
Local or Regional Databases
Local or regional research communities and clinical practices are further data sources. Many research datasets are owned by the primary investigator and may be underutilized after primary findings are published. Investigators may not have time or funding to completely query an existing dataset. To locate these datasets, researchers can search publications in their area of interest, with attention to investigators' data collection methods, then contact authors to inquire about secondary analysis opportunities.
Researchers might also locate datasets through local or regional clinical practice organizations. For example, clinical benchmarking or quality improvement activities require providers to collect patient demographic, pregnancy, labor, and birth information. Regional health entities, such as departments of health and hospitals, may also collect clinical data from electronic health records or vital statistics data. Although these local datasets typically include identifiers and require IRB approvals to access, they can be a rich source of data for secondary analysis. Administrative approval for access may require time and data management, and dataset cleaning is often required. However, cost for access to these datasets can be low compared to national datasets. Researchers seeking local datasets should work with their state or county to identify available variables, necessary regulatory approval, and required costs.
Additional Health-Related Datasets
There are a variety of datasets focused on alternative topics that include maternal-child health information. These databases may contain information directly applicable to perinatal health or provide context of larger societal trends affecting health outcomes. For instance, nutrition datasets may include information on breastfeeding or use of nutrition programs by pregnant and lactating women. To provide another example, states may aggregate vital statistics and medical claims data, allowing for questions to be asked of the data beyond what is captured in vital statistics records. Other longitudinal datasets (eg, the Behavioral Risk Factor Surveillance System and the National Longitudinal Survey of Youth) have been used for perinatal or women's health analyses. Names and relevant content of nonperinatal databases with potentially useful information to maternal-child health researchers are provided in Table 3 . Other databases may contain useful information, and researchers should assess their value against strictures surrounding access.
Non-Health-Related Datasets
Non-health-related data can also be used in maternal-child research. Significant quantities of data regarding specific locations and/or populations are collected or aggregated by governments and companies, and this information can provide context for perinatal health trends. One application of nonhealth data in perinatal research is the use of geographic information systems (GIS) to overlay various location-tagged data. 55 Using computer software, researchers integrate census demographic information (eg, race, ethnicity, or population density) with other spatially linked data such as health care facility locations or perinatal outcomes by zip code. 55 Geographic information systems technology has been most commonly used in maternal-child health research to determine health service access and analysis of risk factor distribution. This approach has also been used to assess the effect of toxins on perinatal outcomes 56 and guide population-based interventions. 55 Even without sophisticated modeling, researchers or clinicians can use non-health-related information to capture context. Census data and many other non-health-related datasets are deidentified and do not require IRB approval for use. However, combining datasets might permit identification of individuals and is controversial. 57 While full IRB approval may not be universally needed even when using multiple datasets, researchers should work with the IRB and relevant data-granting bodies to ensure participant protections.
Interactive Websites to Access Merged and Deidentified Datasets
While some research requires a full dataset for statistical manipulation, clinicians or those engaging in quality improvement may wish to query a database to obtain basic information or statistics. Several interactive websites facilitate data access (Table 4) . Since the data are deidentified and available only at the state level, a data use agreement or IRB approval is not required, and there is no charge for data access. The CDC's PRAMStat was previously discussed. Two additional useful sites for perinatal statistics are Peristats and CDC WONDER (Wide-Ranging Online Data for Epidemiologic Research). These websites merge multiple databases, enabling researchers to perform statistical queries and generate maps or charts. Another example of a website facilitating interactive use of multiple datasets is the Interactive Public Use Microdata Series, which permits queries of census data from 1850 onward down to the level of the individual or family. 58 Title V Information System (TVIS) also provides access to perinatal health data reported by the US states, territories, and jurisdictions receiving Title V funding. 59 This interactive website also includes information on the distribution of federal funding and each state's maternal-child health action plan. Data from 2000 onward can be used for website-based statistical queries and downloaded for analysis. However, definitions of variables have changed over time, which may prevent analysis with the entire dataset.
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DISCUSSION
Each of the aforementioned data resources has applications for perinatal research and quality improvement. Researchers conducting secondary analysis benefit from an understanding of the relative merits of each. Perhaps even more important for such research is an understanding of the overall utility, power, and limitations of secondary analysis of perinatal databases.
Limitations of Prospective Randomized Controlled Trials for Perinatal Research
RCTs have long been promoted as the ideal method for systematically determining the effect of interventions on outcomes through distributing all potential confounding influences equally between groups. 61 Experimental research design has distinct advantages and is the optimal design for many clinical questions; however, there are several attributes of prospective and randomized trials that may limit the utility of experimental design when conducting low-risk maternal-child health research. Maternity care experimental research design may not generate results appropriate for clinical translation and may prevent generation of knowledge relevant to vulnerable populations. One major criticism of clinical RCTs is that rigid treatment protocols differ from real-world application of processes, treatments, and medications. Thus, while a clinical RCT may produce extremely relevant information for well women who are willing and able to precisely follow a protocol or whose pregnancy and labor course exactly match the study design, this information may be inappropriate or irrelevant for women who are unable or unwilling to follow the delineated protocol or whose perinatal events unfold differently.
Given the high degree of variability in women's preferences during pregnancy and birth as well as the wide variation in events of healthy pregnancy and birth, we propose that RCTs may not be the optimal study design for addressing certain questions about well women during the childbearing cycle. Because well women frequently may not consent to, persist in, or remain eligible for RCTs, final sample sizes can be small, and results can be distorted by selection bias due to differential dropout. This is especially problematic for research analyzing important morbidity and mortality outcomes, as severe perinatal events are, thankfully, rare. Moreover, women who are racial and ethnic minorities, women of low socioeconomic position, women who are immigrants, and women with less access to health care are underrepresented in prospective research, limiting generalizability of findings. 62 Further concern relates to selective inclusion and exclusion criteria for prospective or randomized trials that often exclude pregnant women from participation, resulting in a paucity of literature on how interventions or medications affect health in pregnancy. 63 Notably, pregnant women were unequivocally excluded from participation in NIH trials from 1977 to 1993. Despite recent loosening of these restrictions, few clinical drug trials include pregnant women due to fear of fetal harm. 64 Approval of prospective research involving pregnant participants often involves lengthy justifications, extremely rigid protections, and intensive external oversight, making it difficult or impossible for researchers to conduct timely studies with immediate clinical relevance. 63 Secondary research using existing datasets can analyze system or intervention effects on the health of pregnant women using data generated during actual medical care, public health surveillance, or administrative record keeping. For all of these reasons, the scientific gold standard of experimental research design may not be the optimal design for the conduct of well-woman perinatal outcomes research and quality assessment questions. With full awareness of the strengths and limitations of both experimental and observational study design, each perinatal research team can determine which approach is superior for addressing the specific question they seek to answer.
Causal Inference
There are a number of strategies to address limitations encountered when conducting research utilizing existing data. Causal inference approaches have applications in RCTs and are not exclusive to secondary data, 65, 66 but have received increasing attention as one overarching framework and set of methods to strengthen retrospective design and secondary data analysis, to ensure that effects estimated from such studies are valid. 67 Because existing data often reflect actual care processes of women and clinicians (including their preferences for treatment options), it is likely that the differences between groups are not due solely to the effect of the intervention or treatment. Causal inference approaches vary in the specifics (with a lack of consensus as to what constitutes a causal model), but all invoke causal assumptions that, if satisfied, enable the researcher to attribute an association to causation rather than some competing explanation (eg, bias). 15, 68 These causal assumptions are distinct from the statistical assumptions required for unbiased estimation from a regression model. 69 By explicitly identifying and engaging with these assumptions (only some of which are testable), the investigator can minimize the chance that bias (eg, confounding bias, selection bias, overadjustment bias) explains the calculated findings. Some approaches for causal inference utilize the counterfactual framework to improve estimation of the association between cause and effect 70 ; such approaches have multidisciplinary roots in philosophy, statistics, epidemiology, economics, and computer science. 15, 65, 68, 70 Causal inference approaches provide the tools and theory to move beyond the dictum that "correlation does not equal causation" and determine under which circumstances a causal association may underlie correlation. An explicit causal framework formalizes the researchers' knowledge of relationships between exposure, outcome, confounding versus mediating variables, selection variables, and in recent years, missingness and measurement error as well. 71, 72 Then, the investigator may use existing data and appropriate methods to estimate a causal quantity of interest.
Some approaches (eg, propensity score matching) generate a control or comparison group to provide information about what might have happened to individuals had they not been exposed to the intervention. 73 An example of this approach is the use of propensity score analysis to enhance balance between samples of women who chose group or individual prenatal care. 74, 75 Other approaches (such as instrumental variables and regression discontinuity analyses) exploit exogenous changes in the exposure variable (ie, changes that are unrelated to confounding variables or any other variable in the data system) to explore how exposure affects the outcome under study. 76, 77 What these approaches and others share is that they explicitly state the investigator assumptions to infer that a calculated association represents a causal effect, rather than a spurious association resulting from bias. More thorough exploration of causal inference is beyond the scope of this article and has been addressed outside of the maternal-child outcomes literature. 15, 70 Application of the causal inference framework and methods to well-woman childbearing science will be an important area for future consideration.
CONCLUSION
Secondary analysis of existing datasets has many advantages for scientific and quality improvement activities. RCTs involving women who are pregnant or of childbearing age are challenging to conduct, and RCT results may not accurately reflect clinical outcomes with more diverse women or treatment styles nor capture rare perinatal outcomes. There is a wide variety of publicly available datasets for study of US perinatal outcomes. While research using existing datasets must address important limitations, these datasets, coupled with appropriate analytical methodology, can be used to feasibly and ethically generate adequately powered, clinically relevant, and immediately translational maternal-child health care outcomes science. The causal inference framework for research design and analysis includes approaches that strengthen secondary data analysis research. Increased utilization of the multiple existing maternal-child health data sources, paired with use of appropriate analytic techniques, holds promise for accelerating well-woman perinatal outcomes investigation and strengthening the evidence base for perinatal care of lowrisk women and their children. 
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